A Combination of PD-1 and TIGIT Checkpoint Blockade Elicits a Strong Antitumor Response in the Patient and Mouse Pleural Mesothelioma Model

被引：0
|
作者：
Shi, H. [1 ]
Johnson, B. [1 ]
Yu, T. -K. [1 ]
Zhuang, L. [1 ]
Selvamani, S. P. [1 ]
Lee, K. [2 ]
Klebe, S. [3 ]
Chen, K. [4 ]
Clark, G. [4 ]
Kao, S. [1 ]
Silveira, P. [4 ]
Cheng, Y. Y. [5 ]
机构：
[1] Asbestos Dis Res Inst, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Flinders Hlth & Med Res Inst, Adelaide, SA, Australia
[4] Anzac Res Inst, Sydney, NSW, Australia
[5] Inst Biomed Mat & Devices IBMD, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
pleural mesothelioma; immune checkpoint inhibitor; mouse model;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.21-02
引用
收藏
页码：S388 / S388
页数：1
相关论文
共 50 条
  • [31] Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model
    Song, Yujie
    Liu, Qingtian
    Zuo, Tong
    Wei, Guoyan
    Jiao, Shunchang
    CELLULAR IMMUNOLOGY, 2020, 352
  • [32] Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma
    van Gulijk, Mandy
    Belderbos, Bob
    Dumoulin, Daphne
    Cornelissen, Robin
    Bezemer, Koen
    Klaase, Larissa
    Dammeijer, Floris
    Aerts, Joachim
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (07) : 1438 - 1443
  • [33] PARP Targeted Alpha-Particle Therapy Enhances Response to PD-1 Immune-Checkpoint Blockade in a Syngeneic Mouse Model of Glioblastoma
    Dabagian, Hannah
    Taghvaee, Tahereh
    Martorano, Paul
    Martinez, Daniel
    Samanta, Minu
    Watkins, Carolyn M.
    Chai, Richard
    Mansfield, Adam
    Graham, Thomas J.
    Maris, John M.
    Pryma, Daniel A.
    Mach, Robert H.
    Makvandi, Mehran
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (01) : 344 - 351
  • [34] TIGIT and PD-1 Immune Checkpoint Pathways Are Associated With Patient Outcome and Anti-Tumor Immunity in Glioblastoma
    Raphael, Itay
    Kumar, Rajeev
    McCarl, Lauren H.
    Shoger, Karsen
    Wang, Lin
    Sandlesh, Poorva
    Sneiderman, Chaim T.
    Allen, Jordan
    Zhai, Shuyan
    Campagna, Marissa Lynn
    Foster, Alexandra
    Bruno, Tullia C.
    Agnihotri, Sameer
    Hu, Baoli
    Castro, Brandyn A.
    Lieberman, Frank S.
    Broniscer, Alberto
    Diaz, Aaron A.
    Amankulor, Nduka M.
    Rajasundaram, Dhivyaa
    Pollack, Ian F.
    Kohanbash, Gary
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [35] Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells
    Chang, Chien-Hsing
    Wang, Yang
    Li, Rongxiu
    Rossi, Diane L.
    Liu, Donglin
    Rossi, Edmund A.
    Cardillo, Thomas M.
    Goldenberg, David M.
    CANCER RESEARCH, 2017, 77 (19) : 5384 - 5394
  • [36] Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
    Werner, Jan-Michael
    Schweinsberg, Viola
    Schroeter, Michael
    von Reutern, Boris
    Malter, Michael P.
    Schlaak, Max
    Fink, Gereon R.
    Mauch, Cornelia
    Galldiks, Norbert
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [37] Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
    Jo Waaler
    Line Mygland
    Anders Tveita
    Martin Frank Strand
    Nina Therese Solberg
    Petter Angell Olsen
    Aleksandra Aizenshtadt
    Marte Fauskanger
    Kaja Lund
    Shoshy Alam Brinch
    Max Lycke
    Elisabeth Dybing
    Vegard Nygaard
    Sigurd Læines Bøe
    Karen-Marie Heintz
    Eivind Hovig
    Clara Hammarström
    Alexandre Corthay
    Stefan Krauss
    Communications Biology, 3
  • [38] Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
    Waaler, Jo
    Mygland, Line
    Tveita, Anders
    Strand, Martin Frank
    Solberg, Nina Therese
    Olsen, Petter Angell
    Aizenshtadt, Aleksandra
    Fauskanger, Marte
    Lund, Kaja
    Brinch, Shoshy Alam
    Lycke, Max
    Dybing, Elisabeth
    Nygaard, Vegard
    Boe, Sigurd Laeines
    Heintz, Karen-Marie
    Hovig, Eivind
    Hammarstrom, Clara
    Corthay, Alexandre
    Krauss, Stefan
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [39] Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors
    Scognamiglio, Giosue
    De Chiara, Annarosaria
    Parafioriti, Antonina
    Armiraglio, Elisabetta
    Fazioli, Flavio
    Gallo, Michele
    Aversa, Laura
    Camerlingo, Rosa
    Cacciatore, Francesco
    Colella, Gianluca
    Pili, Roberto
    de Nigris, Filomena
    BRITISH JOURNAL OF CANCER, 2019, 121 (11) : 979 - 982
  • [40] Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
    Baruch, Kuti
    Yoles, Eti
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
12345